Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2026-01-04 @ 10:47 AM
Study NCT ID:
NCT03243851
Status:
COMPLETED
Last Update Posted:
2021-09-09
First Post:
2017-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
Sponsor:
Yong-Kil Hong
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KNOG-1501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None